Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany
Main Authors: | , , , , , , |
---|---|
Format: | Journal article |
Published: |
2007
|
_version_ | 1797103114182983680 |
---|---|
author | Liedgens, H Hertel, N Gabriel, A Nuijten, M Dakin, H Sphrer, U Poulsen Nautrup, B |
author_facet | Liedgens, H Hertel, N Gabriel, A Nuijten, M Dakin, H Sphrer, U Poulsen Nautrup, B |
author_sort | Liedgens, H |
collection | OXFORD |
description | |
first_indexed | 2024-03-07T06:15:29Z |
format | Journal article |
id | oxford-uuid:f0f1eab9-4609-4862-b04d-93f9acd37469 |
institution | University of Oxford |
last_indexed | 2024-03-07T06:15:29Z |
publishDate | 2007 |
record_format | dspace |
spelling | oxford-uuid:f0f1eab9-4609-4862-b04d-93f9acd374692022-03-27T11:52:02ZCostutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in GermanyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f0f1eab9-4609-4862-b04d-93f9acd37469Symplectic Elements at Oxford2007Liedgens, HHertel, NGabriel, ANuijten, MDakin, HSphrer, UPoulsen Nautrup, B |
spellingShingle | Liedgens, H Hertel, N Gabriel, A Nuijten, M Dakin, H Sphrer, U Poulsen Nautrup, B Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany |
title | Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany |
title_full | Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany |
title_fullStr | Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany |
title_full_unstemmed | Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany |
title_short | Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany |
title_sort | costutility analysis evaluating the lidocaine 5 medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in germany |
work_keys_str_mv | AT liedgensh costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany AT herteln costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany AT gabriela costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany AT nuijtenm costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany AT dakinh costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany AT sphreru costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany AT poulsennautrupb costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany |